Heart-type fatty acid-binding protein reciprocally regulates glucose and fatty acid utilization during exercise

American Journal of Physiology - Endocrinology and Metabolism

Volumn 288, Issue 2 51-2, 2005, Pages

  Shearer, Jane ^a,b   Fueger, Patrick T ^a,b   Rottman, Jeffrey N ^b   Bracy, Deanna P ^a,b   Binas, Bert ^c   Wasserman, David H ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

Author keywords

15 (p iodophenyl) 3 R,S methylpentadecanoic acid; 2 deoxyglucose; Metabolism; Skeletal muscle; Substrate balance

Indexed keywords

FATTY ACID; FATTY ACID BINDING PROTEIN; GLUCOSE; HEART TYPE FATTY ACID BINDING PROTEIN; LONG CHAIN FATTY ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAROTID ARTERY; CATHETER; CONSCIOUSNESS; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; HEART MUSCLE; HETEROZYGOSITY; HYPOGLYCEMIA; JUGULAR VEIN; METABOLIC CLEARANCE RATE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SHAM FEEDING; SOLEUS MUSCLE; TREADMILL EXERCISE; WILD TYPE;

ANIMALS; BLOOD GLUCOSE; CARRIER PROTEINS; EXERTION; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; HOMEOSTASIS; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; PHYSICAL CONDITIONING, ANIMAL;

EID: 12144255122     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00287.2004     Document Type: Article

References (23)

1. Allen DL, Harrison BC, Sartorius C, Byrnes WC, and Leinwand LA. Mutation of the IIB myosin heavy chain gene results in muscle fiber loss and compensatory hypertrophy. Am J Physiol Cell Physiol 280: C637-C645, 2001.
2. Atkinson LL, Kozak R, Kelly SE, Onay Besikci A, Russell JC, and Lopaschuk GD. Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats. Am J Physiol Endocrinol Metab 284: E923-E930, 2003.
3. Binas B, Danneberg H, McWhir J, Mullins L, and Clark AJ. Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization. FASEB J 13: 805-812, 1999.
4. Binas B, Han X-X, Erol E, Luiken JJFP, Glatz JFC, Dyck DJ, Motazavi R, Adihetty PJ, Hood DA, and Bonen A. A null mutation in H-FABP only partially inhibits skeletal muscle fatty acid metabolism. Am J Physiol Endocrinol Metab 285: E481-E489, 2003.
5. Bonen A, Dyck DJ, and Luiken JJ. Skeletal muscle fatty acid transport and transporters. Adv Exp Med Biol 441: 193-205, 1998.
6. Bonen A, Miskovic D, and Kiens B. Fatty acid transporters (FABPpm, FAT, FATP) in human muscle. Can J Appl Physiol 24: 515-523, 1999.
7. Clavel S, Farout L, Briand M, Briand Y, and Jouanel P. Effect of endurance training and/or fish oil supplemented diet on cytoplasmic fatty acid binding protein in rat skeletal muscles and heart. Eur J Appl Physiol 87: 193-201, 2002.
8. Coburn CT, Knapp FF Jr, Febbraio M, Beets AL, Silverstein RL, and Abumrad NA. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J Biol Chem 275: 32523-32529, 2000.
9. Fernando P, Bonen A, and Hoffman-Goetz L. Predicting submaximal oxygen consumption during treadmill running in mice. Can J Physiol Pharmacol 71: 854-857, 1993.
10. Fueger PT, Bracy DP, Malabanan CM, Pencek RR, and Wassennan DH. Distributed control of glucose uptake by working muscles of conscious mice: roles of transport and phosphorylation. Am J Physiol Endocrinol. Metab 286: E77-E84, 2004.
11. Glatz JF, Schaap FG, Binas B, Bonen A, van der Vusse GJ, and Luiken JJ. Cytoplasmic fatty acid-binding protein facilitates fatty acid utilization by skeletal muscle. Acta Physiol Scand 178: 367-371, 2003.
12. Glatz JF, van Breda E, Keizer HA, de Jong YF, Lakey JR, Rajotte RV, Thompson A, van der Vusse GJ, and Lopaschuk GD. Rat heart fatty acid-binding protein content is increased in experimental diabetes. Biochem Biophys Res Commun 199: 639-646, 1994.
13. Halseth A, Bracy D, and Wasserman DH. Overexpression of hexokinase II increases insulin-and exercise-stimulated muscle glucose uptake in vivo. Am J Physiol Endocrinol Metab 276: E70-E77, 1999.
14. Lopaschuk GD, Belke DD, Gamble J, Itoi T, and Schonekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1213: 263-276, 1994.
15. Luiken JJ, Koonen DP, Coumans WA, Pelsers MM, Binas B, Bonen A, and Glatz JF. Long-chain fatty acid uptake by skeletal muscle is impaired in homozygous, but not heterozygous, heart-type-FABP null mice. Lipids 38: 491-496, 2003.
16. Morgan CR and Lazarow A. Immunoassay of pancreatic and plasma insulin following alloxan injection of rats. Diabetes 14: 669-671, 1965.
17. Murphy EJ, Barcelo-Coblijn G, Binas B, and Glatz JF. Heart fatty acid uptake is decreased in heart-fatty acid binding protein gene-ablated mice. J Biol Chem 279: 34481-34488, 2004.
18. Rottman JN, Bracy D, Malabanan C, Yue Z, Clanton J, and Wasserman DH. Contrasting effects of exercise and NOS inhibition on tissue-specific fatty acid and glucose uptake in mice. Am J Physiol Endocrinol Metab 283: E116-E123, 2002.
19. Schaap FG, Binas B, Danneberg H, van der Vusse GJ, and Glatz JF. Impaired long-chain fatty acid utilization by cardiac myocytes isolated from mice lacking the heart-type fatty acid binding protein gene. Circ Res 85: 329-337, 1999.
20. Schmitt B, Fluck M, Decombaz J, Kreis R, Boesch C, Wittwer M, Graber F, Vogt M, Howald H, and Hoppeler H. Transcriptional adaptations of lipid metabolism in tibialis anterior muscle of endurance-trained athletes. Physiol Genomics 15: 148-157, 2003.
21. Shearer J, Fueger PT, Bracy D, Rottman JN, Clanton JA, and Wasserman DH. Reduced HFABP is protective in the development of dietary-induced insulin resistance (Abstract). Diabetes 53: A337, 2004.
22. Storch J and Thumser AE. The fatty acid transport function of fatty acid-binding proteins. Biochim Biophys Acta 1486: 28-44, 2000.
23. Stremmel W, Pohl L, Ring A, and Hermann T. A new concept of cellular uptake and intracellular trafficking of long-chain fatty acids. Lipids 36: 981-989, 2001.